Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis

Published:2017-06-21 Issue:6 Volume:102 Page:1006-1016
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Checchio T¹,Ahadieh S¹,Gupta P¹,Mandema J²,Puig L³,Wolk R¹,Valdez H⁴,Tan H¹,Krishnaswami S¹,Tallman A⁴,Kaur M⁵,Ito K¹

Affiliation:

1. Pfizer Inc; Groton Connecticut USA

2. Quantitative Solutions Inc.; Menlo Park California USA

3. Department of Dermatology, Hospital de la Santa Creu i Sant Pau; Universitat Autònoma de Barcelona Medical School; Barcelona Spain

4. Pfizer Inc; New York New York USA

5. Pfizer Inc; Collegeville Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.732/fullpdf

Reference14 articles.

2. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions;Menter;J. Am. Acad. Dermatol.,2011

3. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two, randomized, placebo-controlled, phase iii trials;Papp;Br. J. Dermatol.,2015

4. Tofacitinib versus etanercept orplacebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial;Bachelez;Lancet,2015

5. Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial;Bissonnette;Br. J. Dermatol.,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partial Residual Plots as an Integrated Model Diagnostic Tool in Model‐Based Meta‐Analysis;Clinical Pharmacology & Therapeutics;2024-09-08

2. JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review;Expert Review of Clinical Pharmacology;2023-03-31

3. Joint longitudinal model-based meta-analysis of FEV1 and exacerbation rate in randomized COPD trials;Journal of Pharmacokinetics and Pharmacodynamics;2023-03-22

4. VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures;International Journal of Molecular Sciences;2022-08-02

5. Comparative Efficacy of Relapsing Multiple Sclerosis Therapies: Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate;Multiple Sclerosis and Related Disorders;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3